By vgreene, 14 October, 2016 If no fx before/during tx w/ hip BMD T-score >-2.5/no high fx risk: Consider d/c meds (drug holiday) (NOF,14 ASBMR12)
By vgreene, 14 October, 2016 If hip BMD T-score ≤-2.5/high fx risk:13 Consider continued bisphosphonate tx for up to 10y or change to alternative tx (ASBMR12)
By vgreene, 14 October, 2016 If hip/spine/multiple other osteoporotic fx before/during tx: Consider continued bisphosphonate tx or change to alternative tx (ASBMR12)
By vgreene, 14 October, 2016 If new ht loss, back pain/posture change, suspicious CXR finding, or if considering d/c’ing meds: ✓vertebral imaging (NOF9)
By vgreene, 14 October, 2016 Assess tx adherence, diet/supplements (Ca++, vit D),4 exercise,5,6 smoking/EtOH, fall risk factors annually (NOF7,8)
By vgreene, 14 October, 2016 F/U at least annually while on meds, ✓bone turnover markers1 3-6mo after tx initiation, ✓BMD q1-2y (NOF,2 ES3); individualize tx duration
